Eurofins Scientific Listed by nova Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target large, data-rich organisations across critical sectors, listing victims on leak sites to pressure payment and publicise claimed intrusions. In this environment, even partial disclosures can raise legitimate concerns for clients, partners and staff whose information may have been involved.

On 18 July 2025, Eurofins Scientific was listed by the ransomware group known as nova. Public reporting states that internal files were exfiltrated in a ransomware attack. The number of people affected remains unknown, and further technical details have not been released. The listing itself is a claim by the group; independent confirmation of the full scope has not been provided in the available record.

Breaking down the breach

According to the reported facts, Eurofins Scientific appeared on nova’s leak site on 18 July 2025. The incident is described as a ransomware attack in which internal files were allegedly exfiltrated. No public figure has been given for the volume of data taken, the precise date of initial access, the entry method, or the number of individuals whose information may have been involved. Those details remain undisclosed. The organisation has not, in the material available, published a detailed technical timeline or stated the group’s claims beyond the fact of the listing itself.

What is known is limited to the headline claim and the characterisation of the data as internal files obtained during a ransomware incident. Without additional disclosure from the company or independent verification, the exact sequence of events, the systems affected and the duration of unauthorised access cannot be stated as established fact.

Who is nova?

Nova is a ransomware group that has operated by encrypting systems and exfiltrating data, then threatening to publish stolen material on a dedicated leak site if a ransom is not paid. Like other groups in this category, it typically claims responsibility by listing victim organisations and sometimes releasing samples or full archives to demonstrate possession of the data. Public reporting on nova has associated it with double-extortion tactics—combining encryption with data theft—and with opportunistic targeting of organisations that hold commercially or operationally sensitive information.

In this case, the group’s listing of Eurofins Scientific constitutes a claim that it obtained and can release internal files. No further statements attributed specifically to nova about this victim—such as ransom demands, file counts or sample releases—are included in the available facts. Readers should treat the leak-site entry as an unverified assertion until corroborated by the organisation or other independent sources.

About Eurofins Scientific

Eurofins Scientific is a global network of life-sciences companies that provides analytical testing services across multiple industries. It is recognised as a major provider of testing for food, environmental samples, pharmaceuticals and cosmetic products, among other areas. Organisations of this type routinely handle laboratory results, client project data, quality-control records, regulatory submissions and internal operational documents. They also maintain relationships with manufacturers, regulators, research partners and, in some cases, individual consumers whose products or samples are tested.

A breach involving such an organisation is consequential because the data it holds can include commercially sensitive test results, proprietary methods, client identities and, potentially, personal or health-related information linked to samples. Disruption or unauthorised disclosure can affect not only the company itself but also the integrity of supply chains, regulatory compliance and the privacy of people whose materials or records pass through its laboratories.

What data was at risk

The available facts state that internal files were exfiltrated in the ransomware attack. No more granular inventory—such as specific categories of personal data, client lists, laboratory results or employee records—has been publicly named. The exact contents therefore remain unconfirmed.

Organisations in the life-sciences testing sector typically hold a mixture of business and technical information: client contracts and contact details, sample identifiers, analytical results, quality-assurance documentation, research data and internal administrative files. Some of these materials may contain personal data or commercially confidential information. Because the public record does not itemise what was taken, it is not possible to state with certainty which of these categories, if any, were included in the exfiltrated set.

What's at stake

For individuals whose information may have been among the internal files, the practical risks include potential misuse of personal or contact details, targeted phishing that references legitimate laboratory or client relationships, and longer-term concerns about the confidentiality of any health- or product-related data that might have been present. Because the scale and precise data types are unknown, the level of individual exposure cannot be quantified from public sources alone.

For Eurofins Scientific, the stakes include operational disruption from the ransomware event itself, possible regulatory scrutiny depending on the jurisdictions and data types involved, reputational impact with clients who rely on the confidentiality of testing services, and the cost of investigation, remediation and any required notifications. Clients and partners may also face secondary risks if proprietary test data or contractual information was compromised. These consequences remain contingent on the still-undisclosed details of what was actually taken and how it has been handled.

If your data was in this claimed breach

If you have a relationship with Eurofins Scientific—as a client, employee, partner or individual whose samples or records may have been processed—monitor official communications from the organisation for any confirmation of affected data and recommended next steps. Consider placing fraud alerts or credit freezes if you believe personal identifiers could have been involved, and remain alert to phishing or social-engineering attempts that reference laboratory testing or related services. Change passwords on any accounts that reused credentials associated with Eurofins systems, and enable multi-factor authentication where available.

You can also run a free exposure scan of your email address to check whether your information has already appeared in known breach datasets. That check will not confirm or rule out involvement in this specific incident, but it can help you assess whether your details have surfaced elsewhere and take appropriate protective measures.

AICompiled with AI assistance from public sources and published under our editorial standards.